Site Listing

Please choose the site that is most convenient for you

Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Ag
45 locations found